Diabetes drugs are treatments for diabetes by lowering the sugar lower in the blood. Diabetes is a kind of disease with common symptoms such as frequent urination, increased thirst and weight loss. The most common drugs used are insulin and oral medications.
This report contains market size and forecasts of Diabetes Drugs in global, including the following market information:
Global Diabetes Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Diabetes Drugs Market Sales, 2017-2022, 2023-2028, (M Units)
Global top five Diabetes Drugs companies in 2021 (%)
The global Diabetes Drugs market was valued at 55070 million in 2021 and is projected to reach US$ 78860 million by 2028, at a CAGR of 5.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Insulin Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Diabetes Drugs include Sanofi, AstraZeneca, Bayer, Biocon, Boehringer Ingelheim, Dongbao Pharmaceutical, Eli Lilly, Ganlee and Ginwa, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Diabetes Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diabetes Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Units)
Global Diabetes Drugs Market Segment Percentages, by Type, 2021 (%)
Insulin
DPP-4
GLP-1
SGLT-2
Global Diabetes Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Units)
Global Diabetes Drugs Market Segment Percentages, by Application, 2021 (%)
Type 1 Diabetes
Type 2 Diabetes
Global Diabetes Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Units)
Global Diabetes Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Diabetes Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Diabetes Drugs revenues share in global market, 2021 (%)
Key companies Diabetes Drugs sales in global market, 2017-2022 (Estimated), (M Units)
Key companies Diabetes Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
AstraZeneca
Bayer
Biocon
Boehringer Ingelheim
Dongbao Pharmaceutical
Eli Lilly
Ganlee
Ginwa
Guangzhou Baiyun Mountain
Hisun Pharmacy
Hua Dong
Huadong Medicine
Jumpcan Pharmacy
KELUN
Merck & Co.
MSD
North China Pharmaceutical Group Corporation
Novartis
Novo Nordisk
Sanofi
SHIJIAZHUANG YILING PHARMACEUTICAL
Takeda
Taloph
Tianan Pharmaceutical
Tonghua DongBao
Wanbang Biopharmaceuticals